Cargando…
A quantitative measure of treatment response in recent‐onset type 1 diabetes
INTRODUCTION: This paper develops a methodology and defines a measure that can be used to separate subjects that received an experimental therapy into those that benefitted from those that did not in recent‐onset type 1 diabetes. Benefit means a slowing (or arresting) the decline in beta‐cell functi...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375065/ https://www.ncbi.nlm.nih.gov/pubmed/32704564 http://dx.doi.org/10.1002/edm2.143 |